Dreger, Peter <br/><br/>
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.  [electronic resource] 

 -  Blood  Oct 2010 
 - 2438-47 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2010-03-275420  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Genome<br/>Germany<br/>Graft vs Host Disease--pathology<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis<br/>Lymphocyte Transfusion<br/>Middle Aged<br/>Neoplasm, Residual--diagnosis<br/>Prognosis<br/>Prospective Studies<br/>Stem Cell Transplantation--methods<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous--methods<br/>Treatment Outcome